We speak with Professor Joseph Cherian, CEO of the Asia School of Business (ASB), about the pressures facing U.S. higher education institutions as the Trump administration pulls funding — and what this could mean for ASB. He also shares his views on ASB’s growth potential, key revenue drivers, and whether pursuing further education remains worthwhile for professionals.

Pharmaniaga Post-PN17 Betting Big on Biopharma
23:56

Khairy Jamaluddin: Back in the Running
34:25

Caught in the Chip War: Perspectives from the Netherlands
25:36